7MW3711

DB19298InvestigationalProtein Based Therapies

Developed by Mabwell, 7MW3711 is an antibody-drug conjugate targeting B7-H3.

Mechanism
Curator reviewed
Code names
7MW3711

Resolves to

Targets
Q5ZPR3CD276

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with 7MW3711, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In